Botulinum toxin in the treatment of tardive dystonia.
Chatterjee
A
A
Forrest Gordon
M
M
Giladi
N
N
Trosch
R
R
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D018492:Dopamine Antagonists / Q000009:adverse effects; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D012189:Retrospective Studies
D018492:Dopamine Antagonists; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A